Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

‘Patchy’ UK AHSNs To Be Addressed Ahead Of 2023 Relicensing

Executive Summary

A new remit for the NHS’ innovation vehicles, hopes for Integrated Care Systems and a new diagnostics trends report from Deloitte were on the agenda at a UK life sciences sector policy conference.

You may also be interested in...



MHRA Must Seize UK Digital And Diagnostics Opportunity: ABHI Perspectives On Enabling Regulation – Part 2

IVD and healthtech industry representatives give their views on how the future UK medtech system can be shaped to be agile and responsive to patients’ needs, mindful that the regulator must deliver a standalone regulatory system and functional UKCA marking in less than two years.

UK Medtechs Say Conditional Reimbursement Will Open Doors To Innovation Adoption

As the UK NHS Medtech Funding Mandate finally becomes live, the medtech industry is pressing the case for another mechanism that will allow more innovation onto the UK market.

UK Medtech Industry Points The Signpost At Better Adoption of Innovation

Often seen as complicated to access, beset with high entry barriers and with no guarantee of product adoption, the UK NHS is at once a lucrative and tricky market to succeed in for medtech innovators. A new MedTech Landscape Review, from the AHSN Network, has taken on the tasks of signposting and explaining the system, its adoption pathways and its various tools and programs, in an effort to point the way for manufacturers who want to access the NHS.

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT145632

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel